From which of the following drugs was the man most likely experiencing withdrawal?
Rationale:
The man was most likely experiencing withdrawal from heroin.
Heroin withdrawal symptoms are well-documented and include intense physical and psychological effects such as sweating, nausea, muscle pain, and agitation, which are distinct from stimulant or hallucinogen withdrawal, making heroin the most plausible cause of the withdrawal symptoms described.
B: Cocaine withdrawal primarily involves fatigue and depression rather than the severe physical symptoms typical of opioid withdrawal, making it less likely the source.
C: Amphetamines cause withdrawal symptoms like fatigue and mood swings but lack the intense physical distress and flu-like symptoms characteristic of heroin withdrawal.
D: LSD does not cause physical dependence or classic withdrawal symptoms, so it is an unlikely cause of the man’s withdrawal experience.
Select the ergot compound which is primarily used for dementia
Rationale:
Codergocrine is primarily used for dementia due to its neuroactive properties that improve cerebral blood flow and cognitive function. It acts as a vasodilator and modulates neurotransmitter activity, making it effective in managing symptoms of dementia and related cognitive impairments. This differentiates it from other ergot compounds mainly used for vascular or migraine-related conditions.
A: Bromocriptine is mainly a dopamine agonist used in Parkinson’s disease and hyperprolactinemia, lacking significant effects on cognitive function or cerebral blood flow relevant to dementia treatment.
B: Ergotamine is primarily employed for migraine relief through vasoconstriction, which contrasts with the vasodilatory and neuroprotective actions needed to address dementia symptoms.
D: Methysergide serves as a serotonin antagonist useful in migraine prophylaxis, without the neurovascular modulation necessary for treating dementia-related cognitive decline.
Glycopyrrolate is the preferred antimuscarinic drug for use before and during surgery because
Rationale:
Glycopyrrolate is preferred because it is potent, fast-acting, lacks central nervous system effects, and provides both antisecretory and vagolytic actions. This combination makes it ideal for managing secretions and heart rate during surgery without causing sedation or cognitive impairment, ensuring patient safety and optimal surgical conditions.
A: It is potent and fast acting highlights only two benefits, omitting its lack of central action and combined antisecretory and vagolytic properties crucial for surgical use.
B: It has no central action references one advantage but excludes its potency and dual antisecretory and vagolytic effects essential for comprehensive surgical management.
C: It has antisecretory and vagolytic actions focuses on secretions and heart rate control, missing its rapid onset and absence of central nervous system involvement vital in surgery.
Atropine is contraindicated in
Rationale:
Atropine is contraindicated in none of the above.
D is accurate because atropine, a muscarinic antagonist, does not have contraindications related to cyclic AMP, inositol trisphosphate, or diacyl glycerols, which are intracellular signaling molecules rather than clinical conditions or patient states. Its contraindications depend on clinical scenarios, not these biochemical compounds.
A: Cyclic AMP is a signaling molecule unrelated to atropine's contraindications; atropine’s effects are mediated through muscarinic receptor blockade, not through cyclic AMP pathways.
B: Inositol trisphosphate functions as a second messenger in calcium release, irrelevant to atropine’s clinical contraindications, which are not linked to this intracellular messenger.
C: Diacyl glycerols serve as intracellular messengers in signal transduction; atropine’s contraindications do not pertain to these biochemical agents but to patient health status.
Which one of the following is least likely to be useful in the therapy of hypercalcemia?
Rationale:
Thiazide diuretics are least likely to be useful in the therapy of hypercalcemia. Thiazides reduce urinary calcium excretion, which can raise serum calcium levels, worsening hypercalcemia. In contrast, glucocorticoids, plicamycin, and phosphate infusion actively lower serum calcium or counteract its effects, making them more appropriate therapeutic options for managing elevated calcium concentrations.
B: Glucocorticoids decrease calcium absorption and promote renal calcium excretion, effectively lowering serum calcium in hypercalcemia, particularly when caused by vitamin D excess or certain malignancies.
C: Plicamycin binds to DNA, inhibiting osteoclast-mediated bone resorption, thus reducing calcium release into the bloodstream and aiding in hypercalcemia treatment.
D: Parenteral infusion of phosphate precipitates calcium, reducing serum calcium concentrations by forming insoluble calcium phosphate complexes, providing a direct method for lowering hypercalcemia.
While undergoing a surgical procedure a patient develops hypotension. Which of the following drugs can be injected intramuscularly to raise his BP
Rationale:
Mephentermine can be injected intramuscularly to raise blood pressure during hypotension in surgery. It acts as a sympathomimetic agent, stimulating release of norepinephrine, causing vasoconstriction and increased cardiac output, effectively elevating blood pressure. Its suitability for IM administration makes it preferable in acute hypotensive states where intravenous access might be delayed or unavailable.
A: Noradrenaline primarily requires intravenous administration due to its potent vasoconstrictive effects and rapid metabolism, making intramuscular use impractical and unsafe for immediate blood pressure correction.
B: Isoprenaline mainly acts as a beta-adrenergic agonist causing vasodilation and increased heart rate, which may lower blood pressure rather than raise it in hypotensive patients.
D: Isoxsuprine is a vasodilator used to improve peripheral circulation, thus it lowers vascular resistance and is unsuitable for increasing blood pressure during hypotension.
Which of the following drugs would be most appropriate for the 49-year-old woman complaining of difficulty sleeping?
Rationale:
Eszopiclone is most appropriate for the 49-year-old woman complaining of difficulty sleeping. Eszopiclone is a non-benzodiazepine hypnotic specifically designed to treat insomnia by facilitating sleep onset and maintenance with fewer side effects. Its mechanism targets GABA receptors, promoting sedation without significant next-day impairment, making it suitable for managing acute and chronic sleep disturbances safely and effectively.
A: Flunitrazepam Flunitrazepam is a potent benzodiazepine with high abuse potential and risk of dependence, making it unsuitable for typical insomnia treatment. Its strong sedative effects and legal restrictions limit its use in routine clinical practice.
B: Buspirone Buspirone primarily treats anxiety rather than sleep disorders. It lacks significant sedative properties and does not induce sleep, rendering it ineffective for addressing primary insomnia symptoms.
D: Fluoxetine Fluoxetine is an SSRI antidepressant that can cause insomnia or sleep disturbances as side effects, thus it is inappropriate for treating difficulty sleeping and may worsen the patient’s condition.
Which of the following drugs most likely interacted with metoclopramide, thus triggering the adverse effects reported by the patient?
Rationale:
Metoclopramide most likely interacted with amitriptyline, triggering the adverse effects reported by the patient. Amitriptyline, a tricyclic antidepressant, can enhance metoclopramide’s dopaminergic blockade, increasing the risk of extrapyramidal symptoms and central nervous system side effects, thus explaining the patient's symptoms through pharmacodynamic interaction between these two medications.
B: Lithium Lithium primarily affects mood stabilization without significant interaction with metoclopramide’s dopaminergic pathways, making it unlikely to have caused the reported adverse effects via drug interaction.
C: Zolpidem Zolpidem is a sedative-hypnotic acting on GABA receptors without notable influence on dopamine antagonism, therefore it does not precipitate symptoms related to metoclopramide’s mechanism.
D: Paroxetine Paroxetine, a selective serotonin reuptake inhibitor, does not strongly interact with metoclopramide’s dopamine receptor antagonism, reducing the likelihood of causing extrapyramidal or central nervous system adverse effects.
Giving a single IV injection of phenylephrine can be used to normalize a rapid heart rate in paroxysmal supraventricular tachycardia (PSVT). How does phenylephrine do this?
Rationale:
Phenylephrine raises blood pressure, slowing the heart via the baroreceptor reflex.
Phenylephrine is a selective alpha-1 adrenergic receptor agonist that causes vasoconstriction, increasing systemic vascular resistance and blood pressure. This rise activates baroreceptors, triggering a reflex parasympathetic response that decreases heart rate, effectively normalizing the rapid rhythm seen in PSVT without directly acting on cardiac beta receptors or neurotransmitter release.
A: It blocks the beta-receptors on the heart This option misattributes phenylephrine's action; it does not antagonize beta receptors but primarily stimulates alpha-1 receptors causing vasoconstriction rather than direct cardiac beta blockade.
B: It stimulates norepinephrine release from sympathetic nerves to the heart Phenylephrine does not promote norepinephrine release; it directly activates alpha-1 receptors, increasing vascular tone without enhancing sympathetic neurotransmitter secretion at the heart.
D: It stimulates ACh esterase at parasympathetic nerves to the heart Phenylephrine does not influence acetylcholinesterase activity; its mechanism involves vascular constriction and baroreceptor activation, not modulation of parasympathetic enzyme function.
Following drug enhances the evoked release of acetylcholine
Rationale:
4-aminopyridine enhances the evoked release of acetylcholine. This drug blocks voltage-gated potassium channels, prolonging action potential duration in nerve terminals, which increases calcium influx and subsequently promotes greater acetylcholine release at synapses. Its action directly potentiates neurotransmitter exocytosis, distinguishing it as a facilitator of acetylcholine release among the given options.
B: Vesamicol inhibits the vesicular acetylcholine transporter, preventing acetylcholine uptake into synaptic vesicles and reducing release, rather than enhancing it. This mechanism decreases neurotransmitter availability, opposing the effect of increased acetylcholine release.
C: Magnesium ion acts as a calcium channel blocker, suppressing neurotransmitter release by limiting calcium entry into presynaptic terminals, thereby decreasing acetylcholine release instead of facilitating it.
D: None of the above ignores the recognized pharmacological action of 4-aminopyridine, which clearly enhances acetylcholine release, making this option inaccurate.
The neuromuscular blocker having prominent antivagal action is
Rationale:
Pancuronium is the neuromuscular blocker having prominent antivagal action. Pancuronium’s significant antivagal effect leads to increased heart rate by blocking parasympathetic vagal influences on the sinoatrial node, distinguishing it from others. This property is clinically relevant in patients where tachycardia is a consideration, as it influences cardiovascular responses during anesthesia and muscle relaxation.
B: Vecuronium lacks notable antivagal effects and is considered cardiovascularly stable, causing minimal changes in heart rate or vagal tone, making it unsuitable as an agent with prominent antivagal action.
C: Atracurium does not exhibit significant antivagal properties; instead, it is known for histamine release and cardiovascular stability without marked vagal blockade.
D: Gallamine triethiodide has mild to moderate vagolytic activity but is less prominent than pancuronium, thus not primarily recognized for strong antivagal effects.
Which of the following effects of epinephrine would be blocked by phentolamine but not by metoprolol?
Rationale:
Epinephrine’s contraction of radial smooth muscle in the iris would be blocked by phentolamine but not by metoprolol. Phentolamine antagonizes alpha-adrenergic receptors responsible for this contraction, while metoprolol targets beta-adrenergic receptors. Since the radial muscle contraction is mediated by alpha receptors, only phentolamine effectively inhibits this specific epinephrine action, not metoprolol.
A: Cardiac stimulation Metoprolol blocks beta-1 receptors in the heart, preventing epinephrine-induced cardiac effects, whereas phentolamine’s alpha blockade does not influence heart rate or contractility, making this option unrelated to phentolamine’s mechanism.
C: Increase of cAMP in fat Epinephrine raises cAMP via beta receptors stimulating lipolysis; metoprolol blocks beta receptors, stopping this effect. Phentolamine’s alpha blockade does not interfere with cAMP levels in adipose tissue.
D: Relaxation of bronchial smooth muscle Bronchodilation is mediated by beta-2 receptors, inhibited by metoprolol but unaffected by phentolamine. Alpha blockade does not alter bronchial smooth muscle relaxation, excluding this as the correct choice.
Which of the following drugs selectively stimulates $ß2$ adrenoceptors:
Rationale:
Salbutamol selectively stimulates β2 adrenoceptors. Salbutamol is a β2-selective agonist primarily targeting receptors in bronchial smooth muscle, causing bronchodilation without significant β1 cardiac effects. This selectivity makes it effective for asthma treatment by relaxing airway muscles while minimizing heart-related side effects common with non-selective adrenergic drugs.
A: Adrenaline acts on both α and β receptors non-selectively, stimulating β1 and β2 adrenoceptors, thus lacking the selective β2 specificity required here.
B: Noradrenaline predominantly stimulates α and β1 receptors, with minimal β2 activity, making it unsuitable as a selective β2 agonist.
C: Isoprenaline is a non-selective β agonist activating both β1 and β2 receptors, so it does not exclusively target β2 adrenoceptors like salbutamol.
Which of the following molecular actions in the enteric nervous system most likely mediated the adverse effect of the drug in the patient?
Rationale:
Blockade of M receptors most likely mediated the adverse effect of the drug in the patient. Muscarinic (M) receptors in the enteric nervous system regulate gastrointestinal motility and secretion; their inhibition disrupts normal digestive functions, causing symptoms such as constipation or dry mouth. This aligns with common drug-induced side effects involving parasympathetic nervous system interference through M receptor antagonism.
B: Increased serotonergic activity typically enhances gut motility and secretion, which contrasts with adverse effects related to decreased gastrointestinal function caused by drug interference in the enteric nervous system.
C: Activation of β receptors primarily influences smooth muscle relaxation and vasodilation rather than directly mediating adverse gastrointestinal effects linked to the enteric nervous system’s control of motility.
D: Increased adrenergic activity generally suppresses gastrointestinal motility and secretion indirectly, but the primary molecular action in this context involves direct blockade of muscarinic receptors, not adrenergic pathways.
Congenital dopamine-ß-hydroxylase deficiency is characterized by
Rationale:
Congenital dopamine-ß-hydroxylase deficiency is characterized by all of the above. This condition results in absence of norepinephrine and epinephrine due to deficient enzyme activity, leading to accumulation of dopamine. Despite these neurotransmitter imbalances, cholinergic innervation remains intact, making all listed features collectively accurate descriptions of the disorder’s pathophysiology and clinical presentation.
A: Absence of norepinephrine and epinephrine reflects the enzymatic block, but this alone does not encompass the full biochemical and physiological profile of the disorder.
B: Increased concentration of dopamine occurs because dopamine cannot be converted to norepinephrine, yet this alone is insufficient to describe the entire syndrome.
C: Intact cholinergic innervation exists despite the catecholamine deficiencies, but this fact alone does not capture the complete clinical spectrum.
Concerning Alpha blockers, which of the following is CORRECT:
Rationale:
Prazosin can block Alpha1 receptor only.
Prazosin is a selective Alpha1 adrenergic receptor antagonist, leading to vasodilation and decreased blood pressure without significant effects on Alpha2 receptors. Its specificity makes it effective for hypertension treatment by targeting vascular smooth muscle, avoiding central nervous system side effects related to Alpha2 blockade, distinguishing it from non-selective alpha blockers.
A: Phentolamine is selective Alpha1 blocker This is inaccurate because phentolamine is a non-selective alpha blocker, antagonizing both Alpha1 and Alpha2 receptors, causing broader effects on vascular tone and neurotransmitter release.
B: Alpha2 blockers decrease noradrenaline release Alpha2 blockers actually increase noradrenaline release by inhibiting presynaptic feedback inhibition, thus enhancing sympathetic activity, contrary to the statement’s claim about decreased release.
D: They decrease both BP and HR Alpha blockers primarily reduce blood pressure by vasodilation but often induce reflex tachycardia, increasing heart rate rather than decreasing it, contradicting the claim of reduced heart rate.
Which alpha blocker is often used to manage symptoms of benign prostatic hyperplasia (BPH)?
Rationale:
Tamsulosin is often used to manage symptoms of benign prostatic hyperplasia (BPH). Tamsulosin selectively blocks alpha-1 receptors in the prostate and bladder neck, relaxing smooth muscle to improve urine flow and reduce BPH symptoms. Its targeted action minimizes blood pressure effects, making it the preferred alpha blocker for urinary symptom relief in BPH patients compared to non-selective agents.
A: Atenolol primarily targets beta-1 adrenergic receptors to manage cardiovascular conditions like hypertension and angina, lacking any effect on alpha receptors or urinary symptoms related to BPH.
C: Lisinopril is an ACE inhibitor used to treat hypertension and heart failure, without any mechanism to relax prostate smooth muscle or alleviate BPH-related urinary obstruction.
D: Metoprolol is a beta-1 selective blocker indicated for cardiac conditions and does not influence alpha-1 receptors or relieve symptoms associated with benign prostatic hyperplasia.
Which of the following situations constitutes an added risk of digoxin toxicity?
Rationale:
Starting administration of quinidine constitutes an added risk of digoxin toxicity. Quinidine decreases digoxin clearance by displacing it from tissue binding sites and inhibiting P-glycoprotein, leading to elevated serum digoxin levels and increased toxicity risk. This interaction requires careful monitoring to avoid adverse effects, making quinidine the most significant risk factor among the options given for digoxin toxicity.
A: Starting administration of captopril does not significantly alter digoxin metabolism or clearance, thus it lacks the direct pharmacokinetic interaction that increases digoxin toxicity risk.
C: Hyperkalemia actually reduces digoxin toxicity risk by competing with digoxin at its binding sites on the Na+/K+ ATPase, thereby mitigating digoxin’s toxic effects.
D: Hypermagnesemia does not have a notable impact on digoxin pharmacodynamics or pharmacokinetics and therefore does not elevate the risk of digoxin toxicity.
Which of the following drugs is used as inhalation as a bronchodilator and may be used when cough is a pronounced symptom in asthmatic patient?
Rationale:
Ipratropium is used as inhalation as a bronchodilator and may be used when cough is a pronounced symptom in asthmatic patients. It acts by blocking muscarinic receptors in the airways, leading to bronchodilation, and is effective in reducing bronchospasm and cough associated with asthma, making it suitable for inhalation therapy in such cases.
A: Atropine primarily serves systemic anticholinergic functions and is not typically administered via inhalation for asthma due to its side effects and limited bronchodilatory use.
B: Homatropine is mainly an ophthalmic agent for eye examinations and lacks bronchodilatory effects or inhalation use in asthma management.
D: Tropicamide is used as a mydriatic agent in ophthalmology and does not possess bronchodilator properties or suitability for inhalation in asthma treatment.
The neurotransmitter released at the end of most sympathetic nerve fibers is:
Rationale:
Noradrenaline is the neurotransmitter released at the end of most sympathetic nerve fibers. This neurotransmitter primarily mediates the fight-or-flight response by binding to adrenergic receptors, facilitating increased heart rate, blood pressure, and energy mobilization, which are hallmark functions of sympathetic nervous system activation. It plays a crucial role in transmitting signals from nerve endings to target organs during sympathetic stimulation.
A: Epinephrine is mainly secreted by the adrenal medulla into the bloodstream, not directly released at sympathetic nerve endings, thus it does not serve as the primary neurotransmitter at these nerve terminals.
C: Acetylcholine acts predominantly in parasympathetic nerve endings and preganglionic sympathetic fibers, not as the main neurotransmitter released at the terminal ends of most postganglionic sympathetic fibers.
D: Acetylcholine esterase is an enzyme responsible for breaking down acetylcholine, not a neurotransmitter released at sympathetic nerve endings, so it cannot transmit nerve signals.
A short acting cycloplegic and mydriatic drug is:
Rationale:
Tropicamide is a short-acting cycloplegic and mydriatic drug. It rapidly induces pupil dilation and cycloplegia with a brief duration, making it ideal for diagnostic eye examinations where quick recovery of accommodation is necessary. Its onset is within 15-30 minutes, and effects typically last 4-6 hours, distinguishing it from longer-acting agents used in clinical practice.
A: Atropine has a prolonged duration of action, often lasting up to two weeks, which makes it unsuitable as a short-acting cycloplegic or mydriatic drug.
B: Homatropine produces intermediate effects but lasts longer than tropicamide, approximately 12-24 hours, making it less appropriate as a short-acting agent.
C: Hyoscine, also known as scopolamine, has a longer duration and sedative properties, differing from the short-acting profile required for quick eye examinations.
Which of the following is a long-acting beta-2 agonist commonly used in the management of asthma and COPD?
Rationale:
Salmeterol is a long-acting beta-2 agonist commonly used in the management of asthma and COPD. It provides prolonged bronchodilation by selectively stimulating beta-2 adrenergic receptors, improving airflow and reducing symptoms over an extended period. Its duration of action distinguishes it from short-acting agents, making it suitable for maintenance therapy rather than immediate relief of bronchospasm.
A: Albuterol acts quickly but is short-acting, primarily used for acute symptom relief, not long-term control.
C: Epinephrine is non-selective, affecting multiple receptors, causing widespread systemic effects unsuitable for chronic asthma or COPD management.
D: Terbutaline is short-acting and mainly utilized for acute bronchospasm, lacking the prolonged duration necessary for maintenance therapy.
The fall in blood pressure caused by d-tubocurarine is due to
Rationale:
The fall in blood pressure caused by d-tubocurarine is due to all of the above factors.
D-tubocurarine induces hypotension through multiple mechanisms: it reduces venous return by causing muscle relaxation, blocks autonomic ganglia leading to vasodilation, and triggers histamine release that causes vascular permeability and dilation, collectively resulting in a significant drop in blood pressure.
A: Reduced venous return alone does not fully account for the hypotensive effect, as other pathways like ganglionic blockade and histamine release contribute significantly.
B: Ganglionic blockade contributes but is insufficient by itself to explain the entire blood pressure decrease caused by d-tubocurarine.
C: Histamine release leads to vasodilation but cannot solely cause the comprehensive hypotension observed without other mechanisms.
Pheochromocytoma is a tumor of the adrenal medulla. The tumor results in extraordinary high blood noradrenaline levels. What drug or drug combination can block all of adrenergic receptors and normalize all the signs and symptoms caused by pheochromocytoma?
Rationale:
Phentolamine plus propranolol can block all adrenergic receptors and normalize the symptoms caused by pheochromocytoma.
Phentolamine is a non-selective alpha-adrenergic antagonist that blocks alpha receptors, preventing vasoconstriction, while propranolol is a non-selective beta blocker that inhibits beta receptors, controlling heart rate and contractility. Their combination ensures comprehensive blockade of both alpha and beta adrenergic effects caused by excessive noradrenaline secretion.
A: Propranolol only blocks beta receptors, leaving alpha receptors unopposed, which can worsen hypertension and vasoconstriction caused by pheochromocytoma.
B: Phentolamine blocks only alpha receptors, so beta receptor-mediated tachycardia and cardiac symptoms remain uncontrolled without beta blockade.
D: Atropine plus phenylephrine affects muscarinic and alpha-1 receptors selectively but does not block beta receptors or provide comprehensive adrenergic blockade needed here.
Following is a tertiary amine anti-muscarinic drug used for Parkinson's disease
Rationale:
Benztropine is a tertiary amine anti-muscarinic drug used specifically for Parkinson's disease. It alleviates extrapyramidal symptoms by blocking central muscarinic receptors and restoring the balance between dopamine and acetylcholine in the basal ganglia. Its lipophilic nature allows it to cross the blood-brain barrier effectively, making it suitable for neurological applications in Parkinson’s management.
B: Dicyclomine primarily treats gastrointestinal disorders like irritable bowel syndrome by reducing smooth muscle spasms; it lacks significant central nervous system penetration needed for Parkinson’s disease treatment.
C: Pirenzepine selectively blocks M1 muscarinic receptors in the stomach, mainly reducing gastric acid secretion, without notable effects on the central nervous system or Parkinsonian symptoms.
D: Tropicamide is used as an ophthalmic agent to induce mydriasis and cycloplegia during eye examinations and does not have therapeutic roles in Parkinson's disease.
Which of the following drugs was most likely prescribed for the 23-year-old woman with anxiety and cognitive difficulties?
Rationale:
Bupropion was most likely prescribed for the 23-year-old woman with anxiety and cognitive difficulties. Bupropion is effective in treating both depressive symptoms and cognitive dysfunction, particularly improving concentration and energy without significant anxiolytic effects, making it suitable for anxiety-related cognitive complaints. It enhances norepinephrine and dopamine, addressing mood and cognitive deficits simultaneously, unlike other options focusing on either anxiety or attention disorders alone.
A: Methylphenidate primarily treats attention-deficit disorders and is stimulating, not typically prescribed for anxiety, which could worsen symptoms. It does not directly address mood or anxiety-related cognitive dysfunction in young adults.
B: Paroxetine is an SSRI targeting anxiety and depression but often causes cognitive dulling or sedation, potentially exacerbating cognitive difficulties rather than improving them in this patient.
D: Guanfacine is mainly used for ADHD and hypertension, acting on alpha-2 receptors to improve attention but lacks evidence for treating anxiety or broader cognitive impairments in young adults.
The motor fibers of n. facialis are:
Rationale:
The motor fibers of n. facialis are axons of the neurons in nucleus n. facialis. This nucleus contains the cell bodies of the motor neurons that innervate muscles of facial expression. These axons exit the brainstem to form the facial nerve, responsible for motor control, contrasting with sensory or parasympathetic fibers originating elsewhere.
A: Dendrites of the neurons of ganglion geniculi represent sensory inputs, not motor outputs, thus they do not form the motor fibers of the facial nerve.
C: Axons of the neurons in nucleus salivatorius superior carry parasympathetic fibers, not motor fibers controlling facial muscles, hence unrelated to the motor component of n. facialis.
D: Axons of the neurons ganglion geniculi involve sensory pathways and do not contribute to the motor fibers of the facial nerve, which originate from a different nucleus.
Which of the following adverse effects is most likely to occur during the therapy?
Rationale:
Pancreatitis is the adverse effect most likely to occur during the therapy. Pancreatitis involves inflammation of the pancreas, often triggered by certain medications or metabolic disturbances related to treatment. This condition manifests with abdominal pain and elevated pancreatic enzymes, making it a common and serious complication requiring prompt recognition and management during ongoing therapy to prevent further morbidity or mortality.
A: Macrocytic anemia results from impaired DNA synthesis causing large red blood cells, typically associated with vitamin B12 or folate deficiency, not commonly linked to this therapy’s mechanism or side effect profile.
B: Hallucinations involve sensory misperceptions usually tied to neurological or psychiatric conditions, rarely induced by this treatment, which primarily affects metabolic or inflammatory pathways rather than central nervous system function.
C: Liver cirrhosis represents chronic liver scarring from prolonged injury, uncommon as an acute therapy adverse event; this condition develops over years, making it unlikely during short-term or monitored therapeutic courses.
Adrenaline is contraindicated in:
Rationale:
Adrenaline is contraindicated in hypertension.
Adrenaline elevates blood pressure by stimulating alpha-adrenergic receptors, causing vasoconstriction, which can dangerously exacerbate pre-existing hypertension. Administering adrenaline in hypertensive patients risks hypertensive crisis, stroke, or cardiac complications, making its use unsafe in such conditions. Therefore, avoiding adrenaline prevents further cardiovascular strain and potential life-threatening events in hypertensive individuals.
A: Cardiac arrest Adrenaline is essential during cardiac arrest to stimulate heart rate and improve coronary perfusion, making it a crucial treatment rather than contraindicated.
B: Acute bronchial asthma Adrenaline acts as a bronchodilator by relaxing airway muscles, providing rapid relief during severe asthma attacks, so it is not contraindicated here.
C: Anaphylactic shock In anaphylaxis, adrenaline reverses life-threatening symptoms by reducing airway swelling and increasing blood pressure, making it a first-line treatment, not contraindicated.
Which of the following organs is innervated only by parasympathetic nerves?
Rationale:
The ciliary muscle is innervated only by parasympathetic nerves. Parasympathetic fibers from the oculomotor nerve control this muscle to adjust lens shape for near vision, with no sympathetic innervation involved. This exclusive parasympathetic control distinguishes the ciliary muscle from other autonomically innervated structures, ensuring precise accommodation without sympathetic influence.
A: Iris muscles Sympathetic nerves innervate the dilator pupillae, while parasympathetic nerves innervate the sphincter pupillae, meaning dual autonomic innervation rather than exclusively parasympathetic.
C: Sweat glands Innervated primarily by sympathetic cholinergic fibers; parasympathetic input is absent in sweat gland control, making this option unsuitable.
D: Splenic capsule Receives sympathetic innervation for vasoconstriction; parasympathetic input is minimal or nonexistent, excluding it from exclusive parasympathetic innervation.